Hicksons continues to grow with latest round of...

Hicksons is pleased to announce its latest promotions marking another step in our commitment to fostering legal talent and leadership.

Media & Podcasts

Dynamic Business: Building Defects: What They...

“It is important to remember that preventing defects not only protects professionals from legal issues but also contributes to their reputation, customer satisfaction, and the overall integrity of the construction industry.” In a recent Dynamic Business article, Partner, Chloe Ellis sheds light on the legal implications of building defects and the challenges it presents for construction professionals. She also provides tips to navigating these issues effectively

Firm News

Hicksons 2023/24 Holiday Closure Period

Hicksons will be closed for a two-week duration over the Christmas and New Year period.

Stay up to date and receive our latest insights directly to your inboxSubscribe Now

Filter by

Blog

Managing psychosocial hazards at work - Code of Practice (July 2022)

In July 2022, Safe Work Australia released a new Code of Practice on an employer’s duty to manage psychosocial hazards in the workplace. The Code of Practice largely follows suit from Safe Work NSW’s publication released in May 2021, which was the first formal guidance provided to employers regarding their obligations in relation to psychosocial risk factors at work. The updated Code of Practice provides a timely reminder of what employers should be doing to try and avoid psychological risks.

Najeh Marhaba
21 Sep 2022

Blog

Eye in the sky – Drones, employees and surveillance

If your work place involves a large site, the use of a drone can be a way monitor many types of risks.

Warwick Ryan
6 Mar 2019

Blog

Clinical Trial approval where potential participants lack the capacity to consent

The Clinical Manager of a Hospital, applied to The NSW Civil and Administrative Tribunal for approval to conduct a clinical trial, a double-blind, randomized, placebo-controlled study to investigate the efficacy and safety of cannabidiol (CBD) which is an add-on therapy in the treatment of tuberous sclerosis complex (TSC) (GWP42003-P Trial) [2017] NSWCATGD 30.

12 Feb 2018

Subscribe to Our Blog

Keeping you connected, Hicksons regularly publishes articles to keep you up to date on the latest developments. To receive these updates via email, please subscribe below and indicate which areas of law you would like to receive information on.